Furthermore, as presented in Figure 4, there were no differences in serum TGF-β1 concentrations in subgroups of patients according to T2DM, obesity, dyslipidemia, duration of symptoms before admission and age group. This evidence concerns the gene TGFB1 and metabolic syndrome.